Pain Pills Online. Abbott Laboratories received regulatory approval for an updated chronic pain management implant device the firm says comes a battery that lasts up to 10 years.
Also, The North Chicago-based medical device maker today announced the Sept. 9 U.S. Food & Drug Administration approval for its Proclaim XR neurostimulation system for people living with chronic pain.
Proclaim XR uses low-dose spinal cord stimulation, mild electric pulses that change pain signals from the brain.
Abbott’s low-dosing system of spinal cord stimulation works with the low-energy BurstDR Stimulation,
Furthermore. “There seems to be a lot of interest in battery technology, and that transcends medicine,” said Dr. Timothy Lubenow, director of the section of pain medicine at Rush University Medical Center.
Proclaim XR’s app-based software means patients won’t need surgery to benefit from system upgrades, the company said.
Spinal cord stimulation as a treatment has been around for more than 50 years, but most of its advances have come within the past five years. The first implantable devices brought to market were non-rechargeable, with battery life ranging from one to three years.
Therefore, Abbott’s newest system allows a doctor to determine the lowest effective dose of stimulation needed for a patient. It uses a low mode of energy in a cycle instead of a standard 24-hour stimulation—for example, 30 seconds of stimulation for every three to six minutes, Lubenow said.
The long battery life means fewer surgeries for patients, which is more cost-effective, said Lubenow, who has done spinal cord stimulation for more than 30 years, and on Sept. 30 will be the first doctor in Illinois to implant the device in a patient.
“Those are things that benefit society as a whole, not just individual patients,” he said. Pain Pills Online